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Abstract Therapeutic drugs uploaded into conjugated con-
ductive polymer matrices deposited on active magnesium
alloys serve as controlled-dose, self-powered drug-delivery
systems. Preferentially, drugs are added into polymer films
in the largest amount possible, mostly to prevent long-term
treatments. However, added drugs can interact with the
polymer matrix affecting either the structure or the final me-
chanical properties of the polymer film. In this work, polypyr-
role films (PPy) electrodeposited on an AZ31 Mg alloy in
ibuprofen and salicylate-containing solutions are investigated
in terms of their uploading capacity, surface morphology and
mechanical properties. The techniques used to investigate the
uploaded PPy films include cyclic voltammetry (CV), scan-
ning electron microscopy (SEM), EDS, and depth-sensing
indentation (DSI). A maximum ibuprofen concentration of
440 ± 40 μg cm−2 was obtained in PPy films in the presence
of sodium salicylate. The release fraction of ibuprofen as a
function of time is fitted to Avrami’s equation. The hardness
and reduced modulus decreased by 54 and 40 %, respectively,
when the PPy films are prepared in the presence of sodium
ibuprofen compared with those prepared in sodium salicylate
only, indicating a more plastic film with ibuprofen.
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Introduction
Polymer films electrodeposited on active metal alloys and
uploaded with various ionic therapeutic drugs are the subject
of current investigations [1–3]. Such studies are encouraged
by the development of biodegradable, biodisposable self-
powered drug-delivery systems [1]. The mechanism
of a self-powered system relies on galvanic coupling between
conductive polymer films deposited on the surface of an active
alloy. Therapeutic drugs are uploaded as dopants into the film,
while the polymer is growing by attracting counterions to
balance the charge [4–6]. Once a self-powered system is im-
planted in a corrosive environment, such as the one encoun-
tered inside the human body, or on the surface of the skin, it
undergoes corrosion. The corroding active alloy pumps electrons
to reduce the polymer, contracts, and releases the therapeutic
drug. Accordingly, a sufficient corrosion-resistant alloy acts as
a biodegradable implant, and in combination with a polymer
film, serves as vehicle to deliver drugs such as risperidone,
dexamethasone, pain relievers, or antibiotics [1, 4].
Typical alloys for self-powered drug release include Mg
(97 % Mg, 2 % Al, 1 % Zn) [1], Mg (99.9 % purity) [2],
sputtered Mg thin films [5], and AZ91D and AZ31 Mg alloys
[7, 8]. These alloys are attractive as theymatch the mechanical
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properties of the human bones. For instance, Mg alloys and
the human bone have an approximate density of 1.74–2.00
and 1.8–2.1 g cm−3, respectively, and an elastic modulus of
41–45 and 130–180 GPa, respectively. Moreover, the com-
pressive yield strength of Mg is 65–100 GPa while the human
bones is 3–20 GPa [9]. One concern however is the corrosion
of biodegradable Mg alloys that can release undesirable
metals such as Al, so biocompatible alloys having a low Al
content, such as AZ31 Mg alloy, are desirable for biomedical
applications [10, 11].
Polypyrrole is one of the most common, biocompatible,
and mechanically robust conductive polymers (CPs) which
has been used for corrosion protection of metals [7, 12–14]
and local drug delivery [4]. The size, steric effects, functional
groups, charge, and chemical structure of the uploaded drug
may affect the polymer nucleation and growth processes and
its mechanical properties [13]. The depth-sensing indentation
(DSI) technique can be used to determine the mean hardness
(H) and reduced modulus (Er) of PPy films electrodeposited
under different circumstances [15–17].
During electrodeposition of the conductive polymer
film on active magnesium alloys, two competitive processes
occur: nucleation and growth of the polymer and
dissolution of the metal. Dopant ions such as salicylate
and oxalate form a passive layer on the Mg surface
and allow polymerization [18, 19]. However, when drugs
are present in the solution, they might be absorbed on the
surface of the active magnesium alloys affecting the CPs
electrodeposition [20]. It has been reported in the literature
that ibuprofen affects the polymerization and structure of
poly(3,4-ethylenedioxythiophene) (PEDOT) and poly(3,4-
ethylenedioxypyrrole) (PEDOP) matrices [6, 21]. Thus, the
amount of drug incorporated into CPs needs to be optimized
[22]. Several alternatives have been suggested to increase the
amount of the drug in the polymer such as nanostructure CPs
[22] or addition of cationic surfactants [23] or heparin that
increases the cation exchange capacity [24].
The aim of this paper is to investigate the effects of sodium
ibuprofen on the morphological structure, mass fraction re-
lease rate, and mechanical properties of electrodeposited PPy
films on AZ31 Mg alloys in 0.5 mol dm−3 sodium salicylate
solution at different ibuprofen (IBU) concentrations, 0.5–
50 × 10−6 mol dm−3. The novelty of this paper is to highlight
the effects of ibuprofen on the quality and properties of PPy
films deposited on AZ31-Mg alloy.
Experimental
Pyrrole monomer (Sigma Aldrich) was double distilled and
stored in a dark flask at low temperature, under a nitrogen
atmosphere. Sodium ibuprofen, (Fluka), sodium salicylate
(Aldrich), and acetone (Fisher Scientific) were of analytical
grade and used as received. All solutions were prepared with
18 mΩ cm (O Purite) deionized water. A 250-μm-thick AZ31
Mg alloy foil (Goodfellow) substrate was used in all
experiments.
A three-electrode glass electrochemical cell connected to a
potentiostat/galvanostat PGSTAT30 (EcoChemie, the
Netherlands) was used. The working electrode was the AZ31
Mg alloy while a 1 cm2 platinum mesh was the counter elec-
trode and a saturated calomel electrode (SCE) the reference.
Prior to the electrochemical experiments, the AZ31 Mg alloy
foil was wet polished with a series of SiC abrasive paper down
to 2000 grade, degreased with acetone, rinsed with deionized
water grade, and sonicated for 10 min. The samples were tape
masked to expose a constant area of 1 cm2 and positioned
vertically 2 cm from the platinum mesh counter electrode.
The polymerization solution consisted of a mixture of
0.5 mol dm−3 pyrrole (Py), 0.5 mol dm−3 sodium salicylate
(SA), and sodium IBU at concentrations of 0.5, 1, 10, and
50 × 10−3 mol dm−3 (hereafter named as SA, SA-Py, and SA-
Py-xIBU, where x is the millimolar concentration). A rest time
of 600 s was routinely applied to all the samples prior to each
electrochemical experiment. The PPy films were grown
potentiodynamically with a continuous N2 stream bubbling
through the electrolyte to remove dissolved O2 that may affect
the oxidation rate of Py or the AZ31 Mg alloy. The linear
potential sweep started at −0.5 V towards +1.0 V vs. SCE at
a scan rate of 20 mV s−1 for 20 cycles until the film reached a
thickness of ca. 20 ± 5 μm, as determined by scanning electron
microscopy (SEM) and optical imaging. All measurements
were made at room temperature (295 K).
Scanning electron micrographs were obtained with a JEOL
JSM-6500F FEG-SEM instrument equipped with an EDS
X-ray analyser, operating under a vacuum of <0.12 Pa,
and an accelerating voltage of 5 keV. A nanoTest Vantage
system (Micro Materials Ltd., Wrexham, UK) was used to
characterize the mechanical properties of the PPy films. The
indentations were performed in load control mode using a
5-μm radius spherical tip to a maximum load of 3 × 10−3 N,
at a loading rate of 0.12 × 10−3 N s−1, with a 100 s holding
time at maximum load. A total of 20 indents were per-
formed on each sample, the results reported correspond to
the mean value with a standard deviation.
The IBU contained in the PPy films prepared on 1 cm2 of
the AZ31 Mg alloy was released in 20 cm3 of 0.9 wt.% NaCl.
Several aliquots of 5 cm3 were collected at regular intervals of
time, and in order to keep the same volume and the sample
completely immersed in solution, the volume was replenished
by an equal amount of fresh NaCl solution. The samples were
analysed in a Neosys-2000, UV-VISIBLE Spectrophotometer,
Scinco Co. Ltd. The concentrations of IBU and SAwere de-
termined spectrophotometrically at wavelengths of 222 and
295 nm, respectively, using calibration curves. Since SA
shows absorption at 222 nm wavelength, it was necessary to
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subtract its absorbance at this wavelength in order to deter-
mine the IBU concentration. The reported data correspond to
an average of at least three experiments. The PPy films were
characterized by a Nicolet 360 FTIR spectrophotometer and




Open-circuit potential (OCP) measurements of the AZ31 Mg
alloy in SA-Py and SA-Py-xIBU solutions obtained during the
600 s rest period are illustrated in Fig. 1. Although AZ31 Mg
alloys are naturally active in aqueous media and possess ex-
tremely high negative redox potentials, the presence of species
capable of forming a stable protective layer, contributes to the
displacement of the OCPs to nobler values [8, 18, 19]. The
AZ31 Mg alloy in SA-Py solution displays an OCP of
−1.75 ± 0.022 V vs. SCE which rapidly changes to a less
negative value of −1.619 ± 0.002 V vs. SCE as is seen in
curve (a) of Fig. 1. A similar trend can be observed for an
AZ31 Mg alloy immersed in SA-Py-(0.5-50) IBU solutions
(Fig. 1(b–f)). The OCP for solutions with IBU content of
0.5 and 1.0 × 10−3 mol dm−3 (curves b and c) is similar to that
in SA solutions (curve a), but for concentrations above
10 × 10−3 mol dm−3 IBU, the OCP becomes muchmore noble
reaching −1.26 V vs. SCE after 600 s as shown in Fig. 1(f))
for 50 × 10−3 mol dm−3 IBU. This occurs because passive
hydroxide/oxide and salicylate magnesium chelate films,
which can further diminish the magnesium dissolution,
contribute to the equilibrium at the alloy/solution interface
[18, 19]. No oscillations, indicating breakdown and recon-
struction of the passive layer, were seen during the OCP
measurements. The movement of the OCP in the positive
direction with increasing concentration suggests that the IBU
contributes to the passivation of the magnesium surface.
Before growing a stable compact PPy film on the surface of
an AZ31Mg alloy, it is critical to leave the sample at the OCP
for at least 600 s in the SA solution to passivate the surface,
otherwise an incomplete PPy film will be formed.
Cyclic voltammograms (CVs) of an AZ31 Mg alloy in
three different electrolytes are shown in Fig. 2. In an SA so-
lution, curve (a), a large oxidation peak at ca. −0.35 V vs. SCE
due to the oxidation of a non-passivatedMg alloy, which is far
away from the OCP (−1.62 V vs. SCE) can be seen. Mg ions
react with salicylate in solution forming a low solubility che-
late complex that precipitates on the metal surface [18]. At
+0.8 V vs. SCE an extended second anodic process is due to
the oxidation of salicylate ions in solution [8]. This process is
irreversible because there is no reduction peak. The analysis of
the oxidation peak at −0.35 V vs. SCE at different potential
sweep rates shows that the peak does not follow a linear rela-
tionship with the scan rate nor with the square root of the scan
rate in the range of 10–70 mV s−1. This suggests that the
oxidation is neither a diffusion-controlled process nor an ad-
sorption, instead, it confirms that the formation of the passiv-
ating chelate layer on the alloy limits diffusion of magnesium
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Fig. 1 OCP vs. time for an AZ31 Mg alloy in 0.5 mol dm−3 Py and
0.5 mol dm−3 SAwith different sodium xIBU concentrations a 0, b 0.5,
c 1, d 5, e 10, and f 50 × 10−3 mol dm−3 monitored over 10 min
Electrode potential, E vs.
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Fig. 2 First-cycle voltammogram of an AZ31Mg alloy in a 0.5 mol dm−3
SA, b 0.5 mol dm−3 SA and 0.5 mol dm−3 Py, and c 0.5 mol dm−3 SA,
0.5 mol dm−3 Py, and 0.5 × 10−3 mol dm−3 IBU at a potential sweep rate of
20 mV s−1
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ions and forms a stable magnesium chelate complex. The peak
shifts towards less negative potentials as the scan rate in-
creases, which is consistent with an irreversible process [25].
The CVresponses for solutions containing SA-Py (curve b)
and SA-Py-0.5IBU (curve c) in Fig. 2 exhibit a similar broad
oxidation peak at slightly positive potentials, ca. −0.3 V vs.
SCE and lower current density compared with the SA solution
(curve a) due to formation of the salicylate complex. In these
solutions, nucleation and growth of the PPy film at a potential
at ca. +0.8 V vs. SCE takes place [8, 25]. The nucleation and
growth processes are evidenced by the crossing potentials at
+0.8 V and +0.73 V vs. SCE for SA-Py and SA-Py-0.5IBU
solutions, respectively, during the reverse scan towards nega-
tive values [8]. At more positive values than the PPy nucle-
ation and crossing potentials, there is a rapid increase in the
current due to the polymerization of Py and the dissolution of
the underlying AZ31 Mg alloy. The two solutions seem to
follow a similar trend, but a higher current density was ob-
served for SA-Py and a more blunt reversal current wave for
SA-Py-0.5IBU, indicating that less PPy film was formed on
the electrode in the presence of IBU.
Influence of concentrations IBU
Figure 3a, 3b shows a series of CVs acquired in solutions with
higher IBU concentrations, i.e., 10 and 50 × 10−3 mol dm−3,
respectively. The first cycles for both concentrations do not
present the characteristic peak due to the formation of the Mg
salicylate film and the current density, due to the polymeriza-
tion of PPy is very low specially during the first cycles, at
more than +0.8 V vs. SCE, as seen in Fig. 2. This suggests
that IBU not only affects the formation of the passive salicy-
late adsorbed layer, but also the nucleation and growth of the
PPy film. As the number of cycles increases the solution with
10 × 10−3 mol dm−3 IBU shows a slight increase in current
density due to the polymerization of Py at >+0.8 V vs. SCE.
However, the PPy film does not form a uniform coating on the
AZ31 Mg alloy surface. Instead, a series of randomly distrib-
uted black PPy spots with poor adherence and several cracks
were formed, which readily detached from the surface reveal-
ing underlying corrosion products. Figure 3b shows that an
increase in the IBU concentration up to 50 × 10−3 mol dm−3
the formation of the PPy film is completely inhibited. Similar
results have been reported in the literature on the effect of IBU
on the electropolymerisation of PEDOP-IBU films, where the
polymerization is suppressed at high IBU concentrations and
films with lower charge capacity are formed [21]. This effect
has been explained in terms of a transition between the ibu-
profen acting as a dopant and becoming a non-dopant inclu-
sion [21]. In this case, the salicylate layer was absent and the
current density was substantially reduced without any poten-
tial crossings that denote the PPy nucleation and growth. It can
be speculated that IBU is adsorbed in theMg alloy limiting the
access of Py to the electrode surface. In addition, the incorpo-
ration of IBU into the polymer structure, either as a dopant or
inclusion, also limits the growth processes of the polymer
likely due to steric effects. IBU is a large molecule in compar-
ison with other counter ions, such as Cl− or ClO4
− used to
balance the charge during the polymerization and changes
nucleation and growth processes [21, 26, 27].
SEMmicrographs of PPy films prepared in SA-Py and SA-
Py-0.5IBU solutions are shown in Fig. 4a–d. The PPy films
formed from SA-Py solutions are black, compact, crack free,
and adherent, see Fig. 4a. High-magnification SEM micro-
graphs of these films (see Fig. 4b) reveal a globular surface
morphology characteristic for PPy films [8]. On the contrary,
PPy films formed in solutions containing ibuprofen shows
uneven surfaces with some scattered pits and cracks as shown
in the SEMmicrograph in Fig. 4c. Higher-magnification SEM
images of this films displayed a mixture of cylindrical, needle-
Electrode potential, E vs. SCE / V
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Fig. 3 Cyclic voltammetry for an AZ31 Mg alloy for 20 cycles at a
potential sweep rate of 20 mV s−1 in a solution containing 0.5 mol dm−3
SA, 0.5 mol dm−3 Py with a 10 × 10−3 mol dm−3 IBU and b
50 × 10−3 mol dm−3 IBU. The electrode was immersed in the solution for
10 min before starting
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like structures with sizes in the order of 3 μm length and
0.5 μm diameter randomly distributed on the surface. These
images show the effect of low concentrations of ibuprofen on
the film structure which confirms the influence of IBU on
the nucleation and growth of PPy films. It can be suggested
that IBU induces a change of nucleation of Py from a two-
dimensional, in which the surface is covered by globular
cauliflower shape structure to a three-dimensional nucle-
ation forming cylindrical, needle-like structures. Similar
polymerization effects were reported by Chebil et al. using
perchlorate and bisphosphate as dopant ions on Ni [26]. The
average film thickness reached for the samples after 20 cycles
was ca. 20 ± 5 μm for the films formed in SA-Py and SA-Py-
0.5IBU solutions measured by SEM and optical microscope
for cross-sectioned samples. Analogous conjugated polymer
systems, such as PEDOP-IBU, develop a roughening of the
surface after releasing the IBU either from the surface or the
bulk polymer [21].
Drug uploading and release
SA and IBU are uploaded into the PPy film during polymer-
ization to balance the charge of the polymer backbone.
Figure 5 shows a horizontal bar plot illustrating the experi-
mental results of the liberation of the IBU when the PPy film
was synthetized in the presence of different concentrations of
IBU. The left-hand side shows the concentrations of IBU (i.e.,
0.0, 0.5, 1.0, and 5.0 × 10−3 mol dm−3) used in solution to
prepare the films in the presence of SA-Py. On the right-hand
side, the figure shows the total amount of IBU released in
0.9 wt.% NaCl solution after 200 h. The calculated amount
of PPy deposited potentiodynamically on 1 cm2 area of the
AZ31 Mg alloy was 3.0 × 10−3 g. The highest load is
414 × 10−6 g/cm2 of IBU for sample 4 which correspond to a
ratio of 138 × 10−3 g g−1 (IBU/PPy). This value is within the
range of concentration of dopants in PPy films which varies
from a few ×10−9 g to several ×10−3 g, either for nanostructured
or chemically assisted drug uploading in PPy films [1, 23]. On
the other hand, IBU released after 5 min elapsed time from a 1-
cm2 drug-loaded matrix from PEDOP-IBU system is between
21.8 ± 1.3 and 25 ± 1.3 × 10−6 g cm−2, more than one order of
magnitude smaller than in this work, for PPy-IBU-SS films
[21]. These large differences are likely due to amore substantial
inclusion of IBU in the film besides the charge storage capacity
and expected differences between the release efficiency of both









Fig. 4 SEM micrographs of the
surface of the PPy film formed
electrochemically on an
AZ31 Mg alloy in 0.5 mol dm−3
SA and 0.5 mol dm−3 Py (a, b)
and 0.5 mol dm−3 SA,
0.5 mol dm−3 Py, and
0.5 × 10−3 mol dm−3 IBU (c, d) by
cyclic voltammetry in a potential
range of −0.5 to 1 V vs. SCE at a
potential sweep rate of 20 mV s−1
for 20 cycles
Fig. 5 Left-hand-side identification number vs. concentration used to
prepare the PPy film and right-hand-side total amount of IBU released
for the film for a period of 200 h in 0.9 wt.%. NaCl solution
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uploaded on PPy films include neurotrophin-3 with a value of
25 × 10−9 g cm−2 on gold-coated Mylar at a PPy film of 3.6–
26 × 10−6 m thickness [22]. Another one is methotrexate on
PPy films with a loading capacity of 24.5 × 10−3 g g−1 [23] and
chlorpromazine with 191 ± 7 × 10−3 g on a 0.126 cm2 Pt disc
coated with 8 ± 2 × 10−6 m thick PPy film [24].
IBU was released from 20 ± 5 × 10−6 m thick PPy film
deposited on one side of 1 cm2 AZ31 Mg alloy immersed in a
0.9 %NaCl solution. The other side of the alloy was bared and
exposed to the NaCl solution. Figure 6 shows a release profile
curve of mass fraction of drug released as a function of time.
At short periods of time (<50 min), the rate of release is high
and tends to level off. This result is consistent with previous
reports in the literature denoting a rapid release at the initial
stages for dexamethasone in 10 wt.%. NaCl solutions and
other systems [1, 4, 28]. Self-powered systems rely on the
dissolution of the substrate metal to reduce the polymer film
and release the incorporated drug. Any through porosity or
cracks in the PPy film can also provide a pathway for chloride
ions to diffuse through to the substrate metal and promote
crevice and pitting corrosion in the PPy/AZ31 Mg alloy inter-
face [28, 29]. This increases the corroding area above the fixed
area at the back of the sample. Moreover, it also accounts for a
large scattering in the data for the release fraction at larger
periods of time, where the error bars enlarge substantially
likely due to the unpredictable corrosion rate (see Fig. 6 for
t > 250 min). This is consistent with previous results reported
in the literature which shows large scattering at longer times,
for self-powered systems [1].
Avrami’s Eq. (1) was used as a model to represent the
fraction release profile X for samples prepared using a concen-
tration of 0.5 × 10−3 mol dm−3 IBU. This equationwas initially
proposed to analyse and predict crystallization processes, but it
can also fit well to diffusion-controlled and potential-assisted
drug release data, particularly for PPy in salicylate media and
different types of drugs [24, 30, 31]. Both Avrami’s parameter,
n, and the release constant, k, are obtained from the slope and
intercept of the Avrami’s plot of ln[−ln(1 − X)] vs. ln t.
X ¼ 1− exp −ktnð Þ ð1Þ
According to the literature, for diffusion-controlled drug re-
lease systems, the Avrami parameter, n, varies from 0.54 to 1
(first order), depending on the contribution of the diffusion
[24, 30, 31]. In the case of self-powered release, the constant,
k, is equal to 0.125, which is within the reported values for
potential-assisted release processes of ionic drugs, but the
Avrami parameter, n, kinetic order parameter, is equal to 0.11,
much smaller than values reported in the literature [24, 31].
Besides these differences, Avrami’s equation describes the
trend of the experimental data obtained for the self-powered
IBU release from PPy films. The contribution of potential dif-
ference and diffusion in self-powered release systems can be
expected due to potential variations across the film [4].
Depth-sensing indentation
The mechanical properties of the PPy films are dependent on
the chemical structure, molecular size and dopant ion concen-
tration [15, 17]. To investigate the effect of ibuprofen in the
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Fig. 6 Mass fraction of IBU released from a 1 cm2 ≈20 × 10−6 m thick PPy
film grown in 0.5 mol dm−3 SA, 0.5 mol dm−3 Py, and 0.5 × 10−3 mol dm−3
IBU. Drug delivery was performed in a 0.9-wt.%. NaCl solution at 296 K.
Experimental results represent the mean values and a standard deviations
over at least three replicas
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Fig. 7 Load-displacement curves for PPy films prepared at different IBU
concentrations: 0, 0.5, 1.0, and 5 × 10−3 mol dm−3 at a constant load of
3 × 10−3 N
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PPy film, a series of 20 indentations along randomly selected
sampling lines were performed on IBU-free and IBU-loaded
PPy films. Figure 7 shows load-displacement curves obtained
from PPy films uploaded with different amounts of ibuprofen.
For each sample, the 3 × 10−3 N load resulted in a different
depth of penetration, with the maximum depth of the indents
in the 5 × 10−3 mol dm−3 doped sample being less than 1 μm,
the indentation interaction volume being confined to the PPy
film and not influenced by the substrate.
Table 1 summarizes the average hardness (H), reduced
modulus (Er), and the ratio between H and Er of the films
investigated, as well as the concentration of IBU in solution
and contained in the PPy film. Comparison of the mechan-
ical properties of ibuprofen-free PPy films with those con-
taining large amounts of ibuprofen (414 × 10−6 ± 40 g cm-2)
showed a decrease in the H and Er ratio of 54 and 40 %,
respectively. The (H/Er) increases 66 % denoting a softer
more elastic material. Sodium ibuprofen is a large molecule
with a single charge, when added into the PPy matrix acts as
an additional ion dopant along with the sodium salicylate
ions to balance the polymer charge. The size of the ibupro-
fen molecule however results in an increase in the gap be-
tween the polymer chains, reducing the strength of the at-
tractive forces between them making polymer chain motion
and deformation easier than IBU-free polymer films [15,
17]. As previously shown vide supra, in the absence of
ibuprofen, PPy films in SA media developed a uniform,
compact, adherent, globular-like structure (Fig. 4a, b). In
contrast, the addition of ibuprofen into the PPy film pro-
duces a less compact, less adherent, cylindrical, needle-like
structure in Fig. 4c, d. There are few reports in the literature
concerning the role that dopant ions play in PPy in terms of
their effects on molecular conformations, charge location,
and structural defects in the polymer chain [32, 33].
Usually, ion dopants induce changes in the polymer confor-
mation that result in either a better alignment or increased
misalignment of the polymer chains and contribute to addi-
tional packaging or unpacking of the polymer matrix [32].
The mechanical properties of the PPy films can be also
modified by the electrosynthesis method used to prepare
the film or by additional heat treatments [34]. This provides
the opportunity to prepare films which are optimized in
terms of their elasticity for specific purposes, such as a more
corrosion protective films or more reliable drug-delivery
systems.
Conclusions
The effects of sodium ibuprofen on the quality of the electro-
deposited PPy films were characterized. A high loading IBU
capacity in the PPy films is desirable for long-term
therapeutical treatments. The amount of IBU incorporated into
the PPy film in this work is higher than that reported in the
literature for other drugs or IBU loaded in PEDOP and
PEDOT matrices. However, additions of IBU to the solution
affect the electrodeposition processes of the film. A transition
from a globular to cylindrical morphology in a PPy film has
been observed for IBU concentrations in solution
>1 × 10−3 mol dm−3. Larger IBU concentrations of
50 × 10−3 mol dm−3 completely inhibit the formation of the
PPy film. Avrami’s equation provides an appropriate fit to the
experimental IBU fraction released from a PPy film in
0.9 wt.% NaCl solutions. IBU also produces substantial
changes in the mechanical properties of the PPy film compared
with IBU-free PPy films. The results indicate up to 54 % re-
duction in H, 40 % reduction in Er, and an increase of 66 % in
H/Er. An increase in the polymer-free volume is themajor cause
for diminishing the mechanical properties of the PPy film. The
outcomes from this investigation require the modelling of a
self-powered drug release mechanism and theoretical predic-
tions of the effects of uploaded drugs on polymer matrix struc-
ture using density functional theory and mechanical models in
order to provide a more thorough understanding of the system.
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Table 1 Mechanical properties









0 0 0.37 ± 0.09 10.2 ± 1.72 0.03
0.5 254 ± 20 0.29 ± 0.07 9.4 ± 2.14 0.03
1 260 ± 20 0.32 ± 0.04 7.8 ± 0.76 0.04
5 414 ± 40 0.20 ± 0.02 4.1 ± 0.36 0.05
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